Application of Nanotechnology in Diagnosis and Therapeutics
437
Gonzalez-Pizarro R, Silva-Abreu M, Calpena AC, Egea MA, Espina M, García ML (2018) Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders
of anterior and posterior segments of the eye. Int J Pharm 547:338–346
Goula D, Remy J, Erbacher P, Wasowicz M, Levi G, Abdallah B, Demeneix B (1998) Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous
system. Gene Ther 5:712
Grosse S et al (2008) In vivo gene delivery in the mouse lung with lactosylated polyethylenimine,
questioning the relevance of in vitro experiments. J Control Release 132:105–112
Guo J, Fisher KA, Darcy R, Cryan JF, O’Driscoll C (2010) Therapeutic targeting in the silent era:
advances in non-viral siRNA delivery. Mol BioSyst 6:1143–1161
Harris JM, Martin NE, Modi M (2001) Pegylation. Clin Pharmacokinet 40:539–551
Hayder M et al (2011) A phosphorus-based dendrimer targets inflammation and osteoclastogenesis
in experimental arthritis. Sci Transl Med 3:81ra35–81ra35
Heller DA, Jeng ES, Yeung T-K, Martinez BM, Moll AE, Gastala JB, Strano MS (2006) Optical
detection of DNA conformational polymorphism on single-walled carbon nanotubes. Science
311:508–511
Hoeller S, Sperger A, Valenta C (2009) Lecithin based nanoemulsions: a comparative study of
the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical
behaviour and skin permeation. Int J Pharm 370:181–186
Huang X, El-Sayed IH, Qian W, El-Sayed MA (2006) Cancer cell imaging and photothermal therapy
in the near-infrared region by using gold nanorods. J Am Chem Soc 128:2115–2120
Huang X, Jain PK, El-Sayed IH, El-Sayed MA (2007) Gold nanoparticles: interesting optical
properties and recent applications in cancer diagnostics and therapy
Hwang H-Y, Kim I-S, Kwon IC, Kim Y-H (2008) Tumor targetability and antitumor effect of
docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release
128:23–31
Jain AK, Das M, Swarnakar NK, Jain S (2011) Engineered PLGA nanoparticles: an emerging
delivery tool in cancer therapeutics. Crit Rev Ther Drug Carrier Syst 28:1–45
Jain V, Gupta A, Pawar VK, Asthana S, Jaiswal AK, Dube A, Chourasia MK (2014) Chitosanassisted immunotherapy for intervention of experimental leishmaniasis via amphotericin Bloaded solid lipid nanoparticles. Appl Biochem Biotechnol 174:1309–1330
Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MaJ (2001) Chitosan nanoparticles as
delivery systems for doxorubicin. J Control Release 73:255–267
Jeong YI, Cho CS, Kim SH, Ko KS, Kim SI, Shim YH, Nah JW (2001) Preparation of poly
(DL-lactide-co-glycolide) nanoparticles without surfactant. J Appl Polym Sci 80:2228–2236
Jiang G et al. (2008a) Hyaluronic acid–polyethyleneimine conjugate for target specific intracellular
delivery of siRNA. Biopolym: Orig Res Biomol 89:635–642
Jiang W, Kim BY, Rutka JT, Chan WC (2008b) Nanoparticle-mediated cellular response is sizedependent. Nat Nanotechnol 3:145
Joshi HM, Bhumkar DR, Joshi K, Pokharkar V, Sastry M (2006) Gold nanoparticles as carriers for
efficient transmucosal insulin delivery. Langmuir 22:300–305
Kabanov A, Gendelman HE (2007) Nanomedicine in the diagnosis and therapy of neurodegenerative
disorders. Prog Polym Sci 32:1054–1082
Kalani M, Yunus R (2012) Effect of supercritical fluid density on nanoencapsulated drug particle
size using the supercritical antisolvent method. Int J Nanomed 7:2165–2172
Kaminskas LM et al (2012) Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution
formulations in mouse and rat tumor models. Mol Pharm 9:422–432
Kao HJ, Lo YL, Lin HR, Yu SP (2006) Characterization of pilocarpine-loaded chitosan/Carbopol
nanoparticles. J Pharm Pharmacol 58:179–186
Kedar U, Phutane P, Shidhaye S, Kadam V (2010) Advances in polymeric micelles for drug delivery
and tumor targeting. Nanomed Nanotechnol Biol Med 6:714–729
437
Gonzalez-Pizarro R, Silva-Abreu M, Calpena AC, Egea MA, Espina M, García ML (2018) Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders
of anterior and posterior segments of the eye. Int J Pharm 547:338–346
Goula D, Remy J, Erbacher P, Wasowicz M, Levi G, Abdallah B, Demeneix B (1998) Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous
system. Gene Ther 5:712
Grosse S et al (2008) In vivo gene delivery in the mouse lung with lactosylated polyethylenimine,
questioning the relevance of in vitro experiments. J Control Release 132:105–112
Guo J, Fisher KA, Darcy R, Cryan JF, O’Driscoll C (2010) Therapeutic targeting in the silent era:
advances in non-viral siRNA delivery. Mol BioSyst 6:1143–1161
Harris JM, Martin NE, Modi M (2001) Pegylation. Clin Pharmacokinet 40:539–551
Hayder M et al (2011) A phosphorus-based dendrimer targets inflammation and osteoclastogenesis
in experimental arthritis. Sci Transl Med 3:81ra35–81ra35
Heller DA, Jeng ES, Yeung T-K, Martinez BM, Moll AE, Gastala JB, Strano MS (2006) Optical
detection of DNA conformational polymorphism on single-walled carbon nanotubes. Science
311:508–511
Hoeller S, Sperger A, Valenta C (2009) Lecithin based nanoemulsions: a comparative study of
the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical
behaviour and skin permeation. Int J Pharm 370:181–186
Huang X, El-Sayed IH, Qian W, El-Sayed MA (2006) Cancer cell imaging and photothermal therapy
in the near-infrared region by using gold nanorods. J Am Chem Soc 128:2115–2120
Huang X, Jain PK, El-Sayed IH, El-Sayed MA (2007) Gold nanoparticles: interesting optical
properties and recent applications in cancer diagnostics and therapy
Hwang H-Y, Kim I-S, Kwon IC, Kim Y-H (2008) Tumor targetability and antitumor effect of
docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release
128:23–31
Jain AK, Das M, Swarnakar NK, Jain S (2011) Engineered PLGA nanoparticles: an emerging
delivery tool in cancer therapeutics. Crit Rev Ther Drug Carrier Syst 28:1–45
Jain V, Gupta A, Pawar VK, Asthana S, Jaiswal AK, Dube A, Chourasia MK (2014) Chitosanassisted immunotherapy for intervention of experimental leishmaniasis via amphotericin Bloaded solid lipid nanoparticles. Appl Biochem Biotechnol 174:1309–1330
Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MaJ (2001) Chitosan nanoparticles as
delivery systems for doxorubicin. J Control Release 73:255–267
Jeong YI, Cho CS, Kim SH, Ko KS, Kim SI, Shim YH, Nah JW (2001) Preparation of poly
(DL-lactide-co-glycolide) nanoparticles without surfactant. J Appl Polym Sci 80:2228–2236
Jiang G et al. (2008a) Hyaluronic acid–polyethyleneimine conjugate for target specific intracellular
delivery of siRNA. Biopolym: Orig Res Biomol 89:635–642
Jiang W, Kim BY, Rutka JT, Chan WC (2008b) Nanoparticle-mediated cellular response is sizedependent. Nat Nanotechnol 3:145
Joshi HM, Bhumkar DR, Joshi K, Pokharkar V, Sastry M (2006) Gold nanoparticles as carriers for
efficient transmucosal insulin delivery. Langmuir 22:300–305
Kabanov A, Gendelman HE (2007) Nanomedicine in the diagnosis and therapy of neurodegenerative
disorders. Prog Polym Sci 32:1054–1082
Kalani M, Yunus R (2012) Effect of supercritical fluid density on nanoencapsulated drug particle
size using the supercritical antisolvent method. Int J Nanomed 7:2165–2172
Kaminskas LM et al (2012) Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution
formulations in mouse and rat tumor models. Mol Pharm 9:422–432
Kao HJ, Lo YL, Lin HR, Yu SP (2006) Characterization of pilocarpine-loaded chitosan/Carbopol
nanoparticles. J Pharm Pharmacol 58:179–186
Kedar U, Phutane P, Shidhaye S, Kadam V (2010) Advances in polymeric micelles for drug delivery
and tumor targeting. Nanomed Nanotechnol Biol Med 6:714–729